Skip to main content

Q&As

Linda Stein Gold
Q&As
06/30/2021
Dr Stein Gold spoke with The Dermatologist regarding her recent research on the fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion (HP/TAZ) prior to her poster presentation at Maui Derm NP+PA Summer 2021.
Dr Stein Gold spoke with The Dermatologist regarding her recent research on the fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion (HP/TAZ) prior to her poster presentation at Maui Derm NP+PA Summer 2021.
Dr Stein Gold spoke with The...
06/30/2021
The Dermatologist
Lebwohl
Q&As
06/30/2021
Dr Mark Lebwohl discusses a May 2021 phase 3 open label study highlighting the long-term efficacy and safety profile of halobetasol propionate 0.01%/tazarotene 0.045% lotion (HP/TAZ) for treating moderate to severe plaque psoriasis.
Dr Mark Lebwohl discusses a May 2021 phase 3 open label study highlighting the long-term efficacy and safety profile of halobetasol propionate 0.01%/tazarotene 0.045% lotion (HP/TAZ) for treating moderate to severe plaque psoriasis.
Dr Mark Lebwohl discusses a May...
06/30/2021
The Dermatologist
Q&As
06/29/2021
Alexa Kimball, MD, MPH, discusses her latest study, “Pregnancy Outcomes in Women With Moderate-to-Severe Psoriasis From the Psoriasis Longitudinal Assessment and Registry (PSOLAR).”
Alexa Kimball, MD, MPH, discusses her latest study, “Pregnancy Outcomes in Women With Moderate-to-Severe Psoriasis From the Psoriasis Longitudinal Assessment and Registry (PSOLAR).”
Alexa Kimball, MD, MPH,...
06/29/2021
The Dermatologist
Q&As
06/16/2021
Joseph F Merola, MD, MMSc, and Seoyoung C Kim, MD, ScD, MSCE, joined The Dermatologist to offer insights and highlight the links between psoriasis and psoriatic arthritis.
Joseph F Merola, MD, MMSc, and Seoyoung C Kim, MD, ScD, MSCE, joined The Dermatologist to offer insights and highlight the links between psoriasis and psoriatic arthritis.
Joseph F Merola, MD, MMSc, and...
06/16/2021
The Dermatologist
Q&As
06/15/2021
Howa Yeung, MD MSc, met with The Dermatologist to discuss his study, “Interactive Session for Residents and Medical Students on Dermatologic Care for Lesbian, Gay, Bisexual, Transgender, and Queer Patients”.
Howa Yeung, MD MSc, met with The Dermatologist to discuss his study, “Interactive Session for Residents and Medical Students on Dermatologic Care for Lesbian, Gay, Bisexual, Transgender, and Queer Patients”.
Howa Yeung, MD MSc, met with The...
06/15/2021
The Dermatologist
Q&As
06/09/2021
Lawrence Eichenfield, MD, met to discuss one of his most recent studies, “Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-blind Studies.”
Lawrence Eichenfield, MD, met to discuss one of his most recent studies, “Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-blind Studies.”
Lawrence Eichenfield, MD, met to...
06/09/2021
The Dermatologist
Jenny E. Murase, MD
Q&As
06/09/2021
Dr Jenny Murase shares her insights and experiences working with dupilumab in various studies she has authored.
Dr Jenny Murase shares her insights and experiences working with dupilumab in various studies she has authored.
Dr Jenny Murase shares her...
06/09/2021
The Dermatologist
Q&As
06/08/2021
Dr Srivastava discusses her study on factors that can affect Mohs outcomes of high-risk squamous cell carcinoma.
Dr Srivastava discusses her study on factors that can affect Mohs outcomes of high-risk squamous cell carcinoma.
Dr Srivastava discusses her...
06/08/2021
The Dermatologist
Q&As
06/02/2021
Dr Jenny Murase shares her insights and experiences working with dupilumab in various studies she has authored.
Dr Jenny Murase shares her insights and experiences working with dupilumab in various studies she has authored.
Dr Jenny Murase shares her...
06/02/2021
The Dermatologist
Dr Amit Garg: Comorbidity Screening in HS
Q&As
05/19/2021
Amit Garg, MD, shares insights into Hidradenitis Suppurativa and discusses his latest study, “Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations”.
Amit Garg, MD, shares insights into Hidradenitis Suppurativa and discusses his latest study, “Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations”.
Amit Garg, MD, shares insights...
05/19/2021
The Dermatologist